The challenges and opportunities involved in the emergence and regulation of pharmaceutical specialties are discussed in relationship to the historical and current developments regarding nuclear pharmacy. The issues of the state board of pharmacy v federal regulation of the practice of pharmacy, drug use control in institutions, and education and training of specialists are explored. The interaction of the National Association of Boards of Pharmacy (NABP) with professional nuclear pharmacy groups in addressing these issues is described.
This is a US government work. There are no restrictions on its use.
Get full access to this article
View all access options for this article.
References
1.
Catizone CA: Pharmacy in the future-how will we regulate? NABPNewsletter17:112-113, 1988
2.
Ice RD and Wright M.: NABP perspectives on nuclear pharmacy regulations, in Friedman BE and Hladik WB (eds): Regulations and Inspections of Nuclear Pharmacies: Proceedings of a National Conference, Albuquerque, University of New Mexico, 1982, pp 69-74
3.
Laven DL: Nuclear pharmacy (Part V): Nuclear pharmacy—a survey of state boards of pharmacy for 1983, Fla J Hosp Pharm4:23-47, 1984
4.
Brodie DC: Drug use control: Keystone to pharmaceutical service, Drug Intell, February 1967, p 63
5.
Jcah: Accrediatation Manual for Hospitals (ed 1983). Chicago, IL, Joint Commission on Accreditation of Hospitals, 1983, pp. 111-114, 137-145, 155-160
6.
Liang FZ, Greenberg RB, Hogan GF: New medicare conditions of participation for hospitals. Am J Hosp Pharm44:1119-1122,1987
7.
Ice RD, Keesee RE, Shaw SM, et al: Final report of the special committee of radiopharmacy. Am J Pharm Ed 39:492, 1975
8.
Sorby DL: Chair report for the committee on resolutions-AACP. Am J Pharm Ed39:482, 1975
9.
Zilz DA: Diagnostic and therapeutic immunology: Pharmacy practice implications for the future. AACP News, Alexandria, VA , March 1987
10.
Nuclear Regulatory Commission: 10 CFR Parts 30, 31, 32, 35, and 40, Medical Use of Byproduct Material, Final Rule, Federal Register51:36932-36968, October 16, 1986
11.
Schlegel JF : Nuclear pharmacist-compounded drugs. Weekly Pharmacy Reports (The Green Sheet), Vol 37, No 39, September 26, 1988
12.
Laven DL: Protecting the pharmacist's professional prerogatives. Am Pharm, NS28 (11):66, 1988
13.
Amole W.: A took to the future of pharmacy—board perspective. NABPNewsletter17:112-113, 1988
